SELECTIVE MEASUREMENT OF ACTIVE HUMAN PROTEASE COAGULATION FACTORS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20140038204A1
SERIAL NO

13943392

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a method for the selective determination of the concentration of an active human protease coagulation factor in a sample, comprising the steps of binding a specific inhibitor of the human protease coagulation factor to a solid phase, letting the human protease coagulation factor contained in the sample bind to the solid phase-bound inhibitor, and detecting the human protease coagulation factor bound to the solid phase-bound inhibitor with a detection reagent.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BAXTER INTERNATIONAL INCONE BAXTER PARKWAY DEERFIELD IL 60015
BAXTER HEALTHCARE S ATHURGAUERSTRASSE 130 GLATTPARK (OPFIKON) 8142

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Engelmaier, Andrea Vienna, AT 8 23
Schwarz, Hans-Peter Vienna, AT 143 1170
Weber, Alfred Vienna, AT 70 334

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation